On the contrary, the association of the unfavorable PNPLA3 allele with CVD risk lacked in a Chinese study considering a cohort of 189 patients with NAFLD and CVD and 242 patients with NAFLD. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.